Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
MASLD Beyond the Liver: A Systemic Driver of Cardiovascular, Renal, and Oncologic Risk
Current Hepatology Reports
December 2026
Liguori A.
Open Access
Helicobacter pylori and metabolic-associated fatty liver disease severity: a meta-analysis
Frontiers in Medicine
1 June 2026
Zhang L.
Open Access
The Influence of Helicobacter pylori Infection on Hepatic Enzymes, Inflammatory Markers, and Hematological Parameters in Patients with Gastritis
Asean Journal of Scientific and Technological Reports
May 2026
Alsiadi W.A.W.
Open Access
Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study
Hepatoma Research
2026
Fan Q.
Open Access
Targeting Helicobacter pylori in liver-impaired populations: a systematic review of efficacy and safety
Journal of Clinical Biochemistry and Nutrition
2025
Mori H.
Open Access
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease
Annals of Hepatology
1 November 2024
Maiorana F.
Open Access
The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease
Plos One
September 2024
Maiorana F.
Open Access
Helicobacter pylori, helicobacteriosis and associated diseases (VIII Moscow Agreements on the diagnosis and treatment of helicobacteriosis in adults and children) A Clinical Guide for Physicians
Experimental and Clinical Gastroenterology
2024
Lazebnik L.B.
Open Access
Value of Helicobacter pylori infection combined with traditional risk factors in predicting the risk of metabolic associated fatty liver disease
Journal of Clinical Hepatology
June 2023
Bao S.
Discussion on the common controversies of Helicobacter pylori infection
Helicobacter
February 2023
Yang H.
Helicobacter Pylori infection and non-alcoholic fatty liver disease. Is there a relationship?
Healthcare in Low Resource Settings
24 January 2023
Mostafa N.R.
Open Access
Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Canadian Journal of Gastroenterology and Hepatology
2023
Xu G.
Open Access
Nonalcoholic Fatty Liver Disease and Helicobacter pylori Infection: Is it Time to Address this Potential Relationship?
Current Vascular Pharmacology
2023
Polyzos S.A.
Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis
Clinical and Experimental Hepatology
2023
Li D.
Open Access
An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?
Frontiers in Cellular and Infection Microbiology
2023
Chen X.
Open Access
Is Helicobacter pylori infection associated with nonalcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study
Sao Paulo Medical Journal
2023
Valadares E.C.
Open Access
Impact of Helicobacter pylori Infection on the Pathogenesis and Management of Nonalcoholic Fatty Liver Disease
Journal of Clinical and Translational Hepatology
2023
Mavilia-Scranton M.G.
Open Access
Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort
Minerva Medica
December 2022
Wernly S.
Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial
Scientific Reports
December 2022
Yu Y.y.
Open Access
Intestinal microbiota in the treatment of metabolically associated fatty liver disease
World Journal of Clinical Cases
6 November 2022
Wang J.S.
Open Access
The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial
Middle East Journal of Digestive Diseases
JANUARY 2022
Jamali A.
Open Access
The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Frontiers in Pharmacology
3 November 2021
Rezaei S.
Open Access